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The somatomedins are insulin-like growth factors that are thought to mediate the actions of pituitary somatotropin (growth hormone) on cartilage and possibly other tissues 198Oa, b) . Pure preparations of somatomedins are not widely available, which limits the production of highly specific antisera to these factors. Monoclonal antibodies produced by the spleen-cell fusion technique of Kiihler & Milstein (1975) have the advantage, compared with conventional antisera, that highly specific antibodies can be produced by using relatively impure antigens (see e.g., Secher & Burke, 1980; Eisenbarth, 198 1) . We therefore investigated the possibility of raising monoclonal antibodies by using a partially purified somatomedin preparation.
Antibodies to somatomedins were detected by their ability to lower the apparent bioassayable level of somatomedins in human serum. The bioassay used was that of Spencer & Taylor (1978) , except that Tris/HCl buffer supplemented with amino acids (Tris-aa; Phillips et al., 1974) was used as incubation medium. The assay utilizes the stimulation of incorporation of 3sS042 -into cartilage by somatomedin. Small (1 mm x 1.5 mm diameter) discs were cut from the costal cartilage of freshly killed 1 6 1 8-week-old pigs, followed by an overnight preincubation in Tris-aa. Test substances were added to Tris-aa together with human serum and NaZ3?3O4 (4pCi/ml). Incubations were carried out for 48 h in 250pl wells of micro-titre plates (Sterilin Ltd.) with two discs per well. The results are expressed as the percentage of label that was incorporated into each disc, and all values represent the means ( +s.E.M.) for four or six discs.
A mouse of the C57-BL-6J strain was immunized with a partially pure preparation of human somatomedin C (approx. 12 units/mg; obtained from Dr. A. T. Holder, Institute of Child Health, University of London) according to the following schedule : 4pg intraperitoneally in complete Freund's adjuvant, 4pg subcutaneously in incomplete Freund's adjuvant 4 and 6 weeks later and, after several months, 200pg intraperitoneally in phosphate buffered saline 4 days before the fusion. Spleen cells from this mouse were fused with myeloma cells of the P3-NSl/l-Ag-4 line as described by Ivanyi & Davies (1980) . By this means, 23 colonies of cells which produced medium that inhibited sulphation-factor activity were obtained. Many of these cell lines subsequently either stopped growing or ceased producing antibodies. Two cell lines (F7A and F7B), originating from separate primary wells, have been cloned by the technique of limiting dilution (Lefkovits & Waldman, 1979) . Media conditioned by these cell lines lowered the apparent bioassayable level of somatomedin in human serum (Fig. 1 ).
An immunoglobulin preparation was made from culture medium conditioned by F7B cells by precipitation of protein with 27% (w/v) Na2S04, followed by extensive dialysis against distilled water. This immunoglobulin preparation also lowered the apparent bioassayable level of somatomedin in human serum.
We conclude therefore that the factor secreted by these cell lines is an antibody which binds to and blocks the action of a factor with somatomedin-like activity. We cannot exclude, however, the possibility that the antibody may interfere in the bioassay in some way other than by directly binding to somatomedin. We into six discs ( r n e a n k s .~.~. ) is shown.
these antibodies, but the labelled material available in our laboratory is rather impure, which may restrict its usefulness in such a test. An alternative approach to the preparation of monoclonal antibodies to somatomedin C has been described by Baxter et al. (1982) , who used ability to bind 'ZSI-labelled somatomedin C in screening for antibody-producing hybridomas. The ability of this antibody to block the biological actions of somatomedins was not reported. , 1981) and that of Hughes (1979) suggests that the situation in membrane-bound receptor preparations from the liver of the pregnant rabbit is more complex in that most bound 1251-labelled human somatotropin can be displaced by both lactogenic and somatogenic hormones, indicating a specificity for the predominant 'receptor' that does not correlate well with biological activity.
Much of the previous work carried out on rabbit liver receptors has employed microsomal membrane preparations; these include plasma membrane together with various other types of cellular membrane. The complex nature of the results obtained with this system could be partly accounted for by the observation that many somatotropin and prolactin receptors are located intracellularly (Bergeron et al., 1978) . It seemed worthwhile therefore to reinvestigate the properties of the receptors using purified plasma membranes, and the results of this investigation are presented here.
Methods and Results
251-labelled human somatotropin was prepared by the 'Iodogen' method of Fraker & Speck (1978), as described by Cadman & Wallis (1981) . Plasma membranes from the liver of pregnant rabbits were isolated by the method of Neville (1968), with scaling up as described by Goldstein & Blecher (1976) to increase the yield. Samples were taken at each stage of purification to test for the purity of plasma membranes by means of marker-enzyme assays and for binding studies. Plasma membranes were solubilized with 0.5% (v/v) Triton X-100 (Shiu & Friesen. 1974; Herington & Veith, 1977; Cadman & Wallis, 1981) .
The binding of 251-labelled human somatotropin to purified plasma membranes was time-and temperature-dependent. Binding was slower at 4°C than at 25°C. Binding of human somatotropin to purified plasma membranes was increased by bivalent cations, Ca2 + being more effective than Mg2 + . In the presence of the univalent cation Na+, binding was no greater than in the absence of metallic cations. Use of the non-ionic detergent Tween 20 (polyoxyethylene sorbitan monolaurate) in the binding assay instead of bovine serum albumin increased the apparent specific binding by lowering the non-specific binding by half. Increasing the concentration of plasma membranes increased specific binding to a maximum of 52% of the total radioactivity added.
Curves showing displacement of 251-labelled human somatotropin from purified plasma membranes and solubilized plasma-membrane receptors by somatotropins and prolactins from various species were very similar, suggesting that solubilization does not substantially affect the binding properties of the receptors. Bovine and sheep somatotropins displaced * 251-labelled human somatotropin with almost the same potency as unlabelled human somatotropin. Various other non-primate mammalian somatotropins (including the rabbit hormone) competed for receptors with much lower potency. Bovine prolactin was more potent than sheep prolactin, but both were fairly effective in displacing ZSI-labelled human somatotropin from receptors, whereas several other prolactins showed very low potency in this system.
Discussion
Previous work has shown that the binding of somatotropins and prolactins from various species to liver-membrane receptors from the late-pregnant rabbit does not accord closely with either the growth-promoting or the lactogenic properties of the hormones (Hughes, 1979; Cadman & Wallis, 1980; Fix et al., 1981; Wallis & Cadman, 1981; Haeuptle et al., 1983) . Such studies suggest that the liver contains several different receptors for hormones of the somatotropin/prolactin family, only some of which mediate growth-promoting or lactogenic actions. This could have been partly explained by the heterogeneity of the microsoma1 membrane preparation used for the binding studies. However, the results obtained here, with receptors from purified plasma membranes, are very similar to those obtained previously with microsomal membranes (Cadman & Wallis, 1981) . We conclude that the heterogeneity of the membrane preparation was not contributing to the complex results obtained previously, and that this complexity reflects the nature of the plasma-membrane-associated receptors themselves.
It has been suggested that the predominant binding sites for human somatotropin are not involved in mediating the lactogenic or somatogenic properties of prolactin or somatotropin in the rabbit. The fact that rabbit somatotropin and prolactin are poor displacers of Z51-labelled human somato-
